CARGOCONNECT-NOVEMBER 2020 - Flipbook - Page 49
multiple regulatory clearances
for each country which can
impact upstream batch and
ould you elaborate
more on the different
elements of your holistic
supply chain and logistics
development strategy? How
are you raising awareness
of the importance of compliance within the sector?
If we talk about the key elements of a pharma supply
chain, or for that matter of fact,
if this will be applicable to any
other industry as well, they will
be demand sensing, procurement, production and distribution. Being in pharma, which is
highly regulated, procurement,
production and distribution
management becomes completely standard operating procedure (SOP) or good manufacturing practice (GMP) driven.
Any change in vendor, batch
size, production process or
transport condition needs to be
pre-approved by regulatory authorities. So, initiatives and process improvements around
these key aspects need to consider regulatory compliance
and approval timeline as well.
Demand sensing particularly becomes a challenge for
new product launches and
with uncertain market conditions, especially for companies
in the generic drug space
where competition is very high
and product substitution is
rampant. Any out of stock situation could mean not just near
but long-term loss of business.
he healthcare and
is highly regulated – does
this make adoption of new
technologies more complicated? How can the market
Pharma is one of the world’s
most regulated industries,
probably third after Nuclear
AI, in my view, can help Indian
manufacturers enter the elite drug
‘discovery’ and ‘design’ stage, helping
the industry move up the value chain.
and Aviation, with well defined
SOPs governed by internationally recognised GMP. I believe,
any new technology and/or
process development is done
keeping in mind the basic
premise and workflow requirement. Adaption in pharma industry at worst would need
some minor tweaking, keeping
in mind the specific nuances
pertaining to this industry.
The challenge we face is
very similar to any other industry when it comes to any
new technology adaption –
up-skilling or training of people and behavioural change.
ow big an impact can AI
and better utilisation of
RWE realistically have on the
drug research and development (R&D) process? Where
will the biggest impact be?
In my opinion, we have not
even touched the tip of the
iceberg when it comes to AI in
pharma. There is tremendous
scope and opportunity in
R&D where AI can play a vital
role in having a positive impact by squeezing development timeline and cost.
Currently, the Indian pharma players are masters in drug
‘development’ and ‘delivery’.
India is one of world’s largest
pharma manufacturers by volume. AI, in my view, can help
Indian manufacturers enter the
elite drug ‘discovery’ and ‘design’ stage, helping the industry move up the value chain.
BUILT TO SUIT & READY
Strategically located on
Mumbai-Nashik Highway (NH3)
12 meter Clear Height
Ideal for 3PL, FMCG, Retail, Furniture, e-Commerce, Electronics, Pharma, Automobile,
Electrical companies and also for other Industries and Corporates
Contact Person: Raj Baldewa + 91 9764442260
Corporate Office: S7/8, 2nd Floor, Eternity Mall, Teen Haath Naka, Thane West-400604, Maharashtra.
On Mumbai-Nasik Highway (Bhiwandi). Email: firstname.lastname@example.org